Apheon Acquires Majority Stake in Longwood
July 16, 2025
Apheon, a pan‑European private equity investor, has acquired a majority stake in Longwood, a Zaragoza‑based distributor and manufacturer of high value‑added In‑Vitro Diagnostics (IVD) equipment and services focused on Next‑Generation Sequencing. Founder Antonio Raichs and CEO Miguel Giralt will remain invested and the partnership aims to expand Longwood's product offering, pursue M&A and accelerate international growth.
- Buyers
- Apheon
- Targets
- Longwood (Diagnóstica Longwood)
- Sellers
- Antonio Raichs and existing shareholders
- Industry
- Medical Devices
- Location
- Aragon, Spain
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.